Adult-onset diseases can be associated with in utero events, but mechanisms for this remain unknown 1,2 . The Polycomb histone methyltransferase Ezh2 stabilizes transcription by depositing repressive marks during development that persist into adulthood 3-9 , but its function in postnatal organ homeostasis is unknown. We show that Ezh2 stabilizes cardiac gene expression and prevents cardiac pathology by repressing the homeodomain transcription factor gene Six1, which functions in cardiac progenitor cells but is stably silenced upon cardiac differentiation 10 . Deletion of Ezh2 in cardiac progenitors caused postnatal myocardial pathology and destabilized cardiac gene expression with activation of Six1-dependent skeletal muscle genes. Six1 induced cardiomyocyte hypertrophy and skeletal muscle gene expression. Furthermore, genetically reducing Six1 levels rescued the pathology of Ezh2-deficient hearts. Thus, Ezh2-mediated repression of Six1 in differentiating cardiac progenitors is essential for stable gene expression and homeostasis in the postnatal heart. Our results suggest that epigenetic dysregulation in embryonic progenitor cells is a predisposing factor for adult disease and dysregulated stress responses.
Adult-onset diseases can be associated with in utero events, but mechanisms for this remain unknown 1,2 . The Polycomb histone methyltransferase Ezh2 stabilizes transcription by depositing repressive marks during development that persist into adulthood [3] [4] [5] [6] [7] [8] [9] , but its function in postnatal organ homeostasis is unknown. We show that Ezh2 stabilizes cardiac gene expression and prevents cardiac pathology by repressing the homeodomain transcription factor gene Six1, which functions in cardiac progenitor cells but is stably silenced upon cardiac differentiation 10 . Deletion of Ezh2 in cardiac progenitors caused postnatal myocardial pathology and destabilized cardiac gene expression with activation of Six1-dependent skeletal muscle genes. Six1 induced cardiomyocyte hypertrophy and skeletal muscle gene expression. Furthermore, genetically reducing Six1 levels rescued the pathology of Ezh2-deficient hearts. Thus, Ezh2-mediated repression of Six1 in differentiating cardiac progenitors is essential for stable gene expression and homeostasis in the postnatal heart. Our results suggest that epigenetic dysregulation in embryonic progenitor cells is a predisposing factor for adult disease and dysregulated stress responses.
Cardiac hypertrophy results from the integration of numerous sig naling pathways that culminate in welldescribed transcriptional net works 11 . In humans, variation in hypertrophy is induced by similar stimuli across populations. Although genetic variation contributes to this phenotypic variability 12 , epigenetic regulatory mechanisms, par ticularly during embryonic development, are largely unexplored 1, 2 . The heart may be particularly sensitive to early events as turnover of human cardiomyocytes is limited over a lifetime 13 .
Epigenetic regulation via histone methylation stabilizes tran scriptional programs in embryonic progenitors and their differ entiated descendants 3, 4 and is likely to be crucial for establishing and maintaining gene expression and stress responses throughout life. Polycomb complexes are candidates for stabilizing cardiac gene expression as they control cell identity and epigenetic memory in other contexts 5 . Ezh2, the major histone methyltransferase of the Polycomb repressor complex 2 (PRC2), trimethylates histone H3 at lysine 27 (H3K27me3). Ezh2 is essential for embryonic develop ment [5] [6] [7] [8] [9] , but its function in organogenesis or postnatal organ main tenance is unknown.
Ezh2 and the related H3K27 methyltransferase Ezh1 (refs. 14,15) are expressed in cardiomyocytes (Supplementary Fig. 1 ), and H3K27me3 increases in cardiac progenitor cells as they differentiate into cardiomyo cytes (Supplementary Fig. 2 ). This suggests that PRC2 functions in the transition from cardiac progenitor to differentiated cardiomyocyte.
To determine the function of PRC2 in the mouse heart, we inac tivated Ezh2 by Cremediated recombination in a subpopulation of cardiac progenitors known as the anterior heart field (AHF), which contribute to the right ventricle, interventricular septum and outflow tract 16 . Mice with loxP sites flanking the catalytic domain-encoding region of Ezh2 (Ezh2 fl/fl ) 6 were crossed with mice expressing Cre recombinase under the control of the Mef2cAHF enhancer (Mef2cAHF<Cre), which is active from embryonic day (E) 7.5 (ref. 16) . AHF progenitors with inactivated Ezh2 did not show increased H3K27me3 levels as they differentiated into cardiomyocytes ( Supplementary Fig. 2c-h ), resulting in decreased Ezh2 and, in more than 80% of right, but not left, ventricular cardiomyocytes, decreased H3K27me3 (Supplementary Fig. 3 ), suggesting that Ezh2 is the major H3K27 histone methyltransferase in the AHF. H3K27me3 levels were not reduced in endothelial cells (Supplementary Fig. 2d ). Mice with Ezh2deficient AHF cells developed normally structured hearts ( Supplementary Fig. 4) . However, Ezh2deficient hearts became enlarged after birth, with increased ratios of heart weight to tibia length (Fig. 1a,b) . Cardiac enlargement was restricted to the right ventricular wall, where cardiac myocytes were massively hypertrophied, with an almost fourfold increase in crosssectional area (Fig. 1c,d ). Echocardio graphy confirmed right ventricular enlargement and showed mild Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis l e t t e r s pulmonary stenosis (Supplementary Table 1 ). Cardiomyocytes were already enlarged in E20 fetuses (Supplementary Fig. 5 ), ruling out altered hemodynamics as a primary cause of hypertrophy. Ezh2deficient right ventricles were fibrotic (Fig. 1e,f) , and the endo cardium was invaginated into the ventricular myocardium (Fig. 1g) , resembling ventricular noncompaction 12, 17 . Thus, loss of Ezh2 in cardiac precursors leads to cardiac hypertrophy and fibrosis.
We examined altered gene expression in Ezh2deficient adult hearts. The hypertrophyassociated genes 18, 19 Nppa, Nppb and Myh7 as well as the profibrotic genes Tgfb3, Postn and Spp1 were highly upregulated l e t t e r s (Fig. 2a,b) . Immunofluorescence detected low levels of Tgfβ3 in the perinuclear region of wildtype cardiac myocytes, whereas Tgfβ3 was enriched in the extracellular region in Ezh2deficient hearts (Fig. 2c) . Thus, Ezh2 might suppress gene expression that promotes cardiac hypertrophy and fibrosis. If Ezh2 acts epigenetically, a sustained requirement for its activity would be anticipated. To address this, we deleted Ezh2 in differ entiating ventricular myocytes using ventricular myocyte-specific Nkx2-5<Cre transgenic mice 20, 21 , which express Cre only after cardiomyocytes begin to differentiate. Ezh2 fl/fl ; Nkx2-5<Cre mice had mild cardiomyocyte hypertrophy and increased Myh7 mRNA levels ( Supplementary Fig. 6 ), perhaps because of reduced Nkx2-5<Cre-mediated recombination efficiency 20, 21 (Supplementary Fig. 3c,d) or a crucial window of activity of Ezh2 during early cardiac progenitor differentiation. Thus, Ezh2 functions in cardiomyocyte progenitors, with longterm consequences.
We hypothesized that Ezh2mediated H3K27me3 directly represses fetal genes and that reactivation of these genes in Ezh2deficient hearts results from loss of epigenetic repression. At the Nppa promoter 19 , occupancy of the PRC2 core subunit Suppressor of zeste 12 homolog (Suz12) and H3K27me3 was decreased in Ezh2deficient hearts, and acetylated histone H3 (AcH3, activating mark) and RNA polymer ase II (Pol II) were increased ( Fig. 2d and Supplementary Fig. 7) . These results suggest that Ezh2 directly represses fetal gene expression to maintain cardiac homeostasis.
We determined the global geneexpression profile of adult Ezh2 deficient right ventricles by RNA sequencing (RNAseq) and DNA microarrays. With a stringent P < 0.001 and foldchange cutoff of >1.4, we found that 1,132 genes were upregulated and 1,800 were down regulated (Supplementary Table 2 ). Consistent with hypertrophy and fibrosis, myocardial remodeling-associated genes (for example, Nppa and Nppb) and atrialspecific genes (Sln and Myl7) were upregu lated in Ezh2deficient hearts (Fig. 2e) . Genes involved in signaling pathways mediating myocardial remodeling were also misregulated (Supplementary Table 3 ). Gene Ontology classification showed that many misregulated genes encode skeletal muscle-specific contractile proteins and developmental regulators (Fig. 2f) , including some that are normally induced during cardiac hypertrophy (for example, Acta1). Thus, Ezh2 is required to stabilize postnatal cardiac gene expression.
In pluripotent cells, Polycomb complexes repress transcription fac tors regulating cell differentiation and development 5 . We hypothesized that Ezh2mediated repression of key transcription factors is required to stabilize cardiac gene expression. Our analyses showed increased expression of the homeodomain transcription factor gene Six1 and its coactivators Eya1, Eya2 and Eya4 (Fig. 2e and Supplementary  Table 2 ) [22] [23] [24] . Six1 functions in noncardiac cell types, including l e t t e r s skeletal muscle. Indeed, many (P < 2 × 10 −8 ) genes misregulated in Ezh2deficient hearts are direct targets of Six1 in differentiating skeletal myoblasts (Fig. 2e) 25 . Six1 targets were preferentially misregulated over nonSix1 targets (Fig. 2g) . Expression of Six1, Eya1 and some skeletal muscle genes was also increased in Ezh2 fl/fl ; Nkx2-5<Cre hearts (Supplementary Fig. 6e ). Six1 functions in early cardiac pro genitors but not in differentiating cardiomyocytes 10 and remains silent in the developing and postnatal heart ( Fig. 3 and Supplementary  Fig. 8 ). Upon loss of Ezh2, Six1 might activate transcription of a subset of skeletal muscle genes in cardiomyocytes, contributing to instability of cardiac gene expression. We addressed the relevance of increased Six1 expression in deregu lating gene expression in Ezh2deficient hearts. Quantitative realtime PCR (qRTPCR) confirmed Six1 derepression in early developing ven tricular myocardium (E10) and exclusively in the adult Ezh2deficient right ventricle (Fig. 3a) , consistent with specific repression by Ezh2.
At E13.5 and in newborn and adult hearts, Six1 expression was increased in Ezh2 deficient right ventricular myocardium (Fig. 3b,c and Supplementary Fig. 8) , and Eya1 was derepressed exclusively in adult cardiomyocytes (Fig. 3b) . Furthermore, upon loss of Ezh2, Six1 protein was expressed in nuclei of adult cardiomyocytes that concomi tantly expressed the skeletal muscle-specific Six1 target Actn3 (Fig. 3c) .
To (Fig. 3d and data not  shown) . Pol II and AcH3 were enriched, con sistent with Six1 derepression. Thus, PRC2 epigenetically represses Six1 expression. Six1 expression is rapidly extinguished upon differentiation of car diac progenitors 10 , but its derepression in Ezh2 fl/fl ; Mef2cAHF<Cre hearts suggests an expression potential in differentiated myocar dium. Computational analysis of the Six1 locus identified a highly conserved sequence in the 5′ noncoding region of Six1 with putative binding motifs for cardiac development regulators Nkx25, Gata4 and Mef2c (Fig. 4a) . To test its potential to drive cardiac expression, we fused this conserved element to a LacZ reporter driven by the Hsp68 promoter and injected the resulting reporter construct (Fig. 4b) into mouse zygote pronuclei. About 50% of transient transgenic embryos (6/12) showed βgalactosidase activity in the myocardium (Fig. 4c-e) , suggesting that this enhancer is active in the heart when not in its endogenous repressed genomic location. This is consistent with a model whereby the cardiac expression potential of the Six1 locus is suppressed in differentiating cardiac progenitors.
We investigated the effect of persistent Six1 and Eya1 expres sion in cardiomyocytes on hypertrophy. Overexpression of Six1, with or without Eya1, in cultured neonatal mouse cardiomyocytes resulted in hypertrophy comparable to that induced by the potent hypertrophic agonist endothelin1 (Fig. 5a) . In addition, Six1 and Eya1 synergistically activated expression of fetal cardiac and skeletal muscle genes ( Fig. 5b and Supplementary Fig. 9 ). l e t t e r s
To determine whether Six1 derepression causes the Ezh2deficient heart phenotype, we reduced Six1 levels in this model. We bred Ezh2 fl/fl ; Mef2cAHF<Cre mice onto a heterozygous Six1-LacZ knockin back ground 23 and analyzed cardiomyocyte hypertrophy and fibrosis in adult mice. Reducing levels of Six1 by 50% in Ezh2deficient hearts significantly normalized heart size, as measured by ratios of heart weight to tibia length (Fig. 6a) . Furthermore, cardiomyocyte size, Tgfβ3 expression and fibrosis were almost completely rescued (Fig. 6b,c and Supplementary Fig. 10) . Skeletal muscle genes, the hypertrophy marker Myh7, and the profibrosis factors Tgfb3 and Postn also returned to normal expression levels ( Fig. 6d and Supplementary  Fig. 10 ). Residual Six1 (Fig. 6d) might account for the persistent phe notype. Evidence points to a direct effect of Six1 misregulation in myocardium and rules out secondary effects caused by an overload of pressure on the outflow tract: Six1 and its target Actn3 are coexpressed in Ezh2deficient cardiomyocytes (Fig. 3c) , and Six1 occupied the Nppa, Myl1 and Tgfb3 loci in Ezh2deficient hearts ( Supplementary  Fig. 11 ). In addition, mild thickening of the pulmonary valve leaflets in Ezh2 fl/fl ; Mef2cAHF<Cre adult hearts (Supplementary Fig. 12 ) was not present in fetal hearts that were already hypertrophied (Supplementary Fig. 5b ) and was not rescued upon decreasing Six1 expression (Supplementary Fig. 12 ), despite a normalization of hypertrophy and fibrosis (Fig. 6b,c) . Thus, myocardial deregula tion of Six1 alone is the major cause of myocardial hypertrophy and fibrosis in Ezh2deficient hearts.
We uncovered a finely regulated epigenetic regulatory mechanism in which Ezh2mediated stable repression of Six1 in differentiating embryonic cardiac progenitors is essential for normal cardiac growth and stressresponsiveness in the adult. Ezh2 modulates a feedforward pathway that represses fetal gene expression and is reinforced by repression of Six1 (Supplementary Fig. 13 ). This represents a previ ously unknown pathway for regulating cardiac growth: neither Ezh2 nor Six1 is upregulated in hearts subjected to hypertrophic stimuli (Supplementary Fig. 14) . Repression of Six1 is required to stabilize cardiac gene expression by preventing activation of skeletal muscle genes in cardiac muscle. Ezh2 loss is probably not sufficient to activate this program by acting merely as a 'brake' , but reactivation of Six1 (the 'gas pedal') and expression of its targets results in pathologic cardiac remodeling with hypertrophy and fibrosis. Mutations in EYA4 cause cardiomyopathy in humans 24 , strengthening the idea that con trol of SIX1 and EYA function is crucial for normal cardiac homeo stasis. Our results suggest that Ezh2mediated repression of Six1 in cardiac progenitors stabilizes postnatal cardiac gene expression, illus trating the importance of epigenetic regulation early in development and its implications in postnatal organ homeostasis.
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